WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 0.5% of their position (750.00 shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $2.3K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/15/2022ACC: 0001213900-22-080102
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+750.00
Net shares
Net buyer
$2.3K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
750.00 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+487.00
Price / share
$3.07
Trade value
$1.49K
% of position
0.3%
12/13/2022
153.77K→154.26K
Common Stock
Direct
Shares
+263.00
Price / share
$3.17
Trade value
$833.68
% of position
0.2%
12/14/2022
154.26K→154.52K
Total
Net shares
+750.00
Net value
$2.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/13/2022 | P · Purchase | +487.00 | $3.07 | $1.49K | 0.3% | 153.77K | 154.26K |
| Common Stock Direct | 12/14/2022 | P · Purchase | +263.00 | $3.17 | $833.68 | 0.2% | 154.26K | 154.52K |
| Total | +750.00 | $2.33K | ||||||
Derivative Transactions0
No derivative transactions reported